Then the need for 2nd IA and/or potential stoppage is what? Would there have been epic panic in all that is AMRN if after 60% it was stated by management, "we'll get back to you at the end of 2017, have a great next 18+ months? IMO 80% is more than just the FDA and AMRN getting together exchanging Valentines Day cards and liking each other on Facebook.
Kiwi quote - "If they stop the trial ,all those in the placebo arm will almost certainly go on Vascepa ....an immediate increase of about 3,500 scripts . "
Good point- but wouldn't it be 7000 scripts - I don't believe they get revenue from scripts in the treated population in a study, do they? That's about an extra $10M/yr right there.
Market Data 
Markets 
AI
